IE
GLMD icon

Israel Englander’s Galmed Pharmaceuticals GLMD Stock Holding History

Israel Englander’s Portfolio GLMD Stock Details GLMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-210
Closed -$12.5K – 6244
2023
Q3 		$12.5K Buy
210
+55
+35% +$5.83K ﹤0.01% 5731
2023
Q2 		$43.4K Buy
155
+64
+70% +$27.7K ﹤0.01% 5502
2023
Q1 		$56K Sell
91
-13
-13% -$11.2K ﹤0.01% 5593
2022
Q4 		$75K Buy
104
+71
+215% +$37.2K ﹤0.01% 5663
2022
Q3 		$15K Sell
33
-2
-6% -$1.36K ﹤0.01% 6535
2022
Q2 		$35K Buy
35
+28
+400% +$37.1K ﹤0.01% 6311
2022
Q1 		$17K Sell
7
-30
-81% -$68K ﹤0.01% 6666
2021
Q4 		$97K Buy
37
+28
+311% +$101K ﹤0.01% 6271
2021
Q3 		$36K Buy
+9
New +$37.8K ﹤0.01% 6621
2020
Q2 		– Sell
-16
Closed -$82K – 4307
2020
Q1 		$82K Buy
16
+6
+60% +$45.6K ﹤0.01% 3589
2019
Q4 		$87K Buy
+10
New +$68.7K ﹤0.01% 4044
2019
Q1 		– Sell
-14
Closed -$141K – 4085
2018
Q4 		$141K Sell
14
-215
-94% -$3M ﹤0.01% 3489
2018
Q3 		$4.48M Buy
229
+10
+5% +$187K 0.01% 1888
2018
Q2 		$3.75M Buy
219
+207
+1,725% +$2.4M ﹤0.01% 1989
2018
Q1 		$94K Buy
+12
New +$140K ﹤0.01% 3486

Other funds holding GLMD

CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $32.7B AUM 35.71% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
BCM
Bourgeon Capital Management Darien, Connecticut $679M AUM 50.89% 1-Year Est. Return

Israel Englander's GLMD Position: Q4 2023 in Review

Israel Englander sold out of Galmed Pharmaceuticals (GLMD) in Q4 2023, closing a stake of 210 shares — an estimated $12.5K sold.

Israel Englander first reported a position in GLMD in Q1 2018 and held it in 15 quarters. The position peaked at $4.48M in Q3 2018. 10 funds tracked by Wall St. Rank hold GLMD as of Q4 2023.

  • Israel Englander reported no remaining Galmed Pharmaceuticals position as of Q4 2023 after selling out during the quarter.
  • Israel Englander sold 210 Galmed Pharmaceuticals shares in Q4 2023, an estimated $12.5K.
  • Israel Englander first reported a position in Galmed Pharmaceuticals in Q1 2018 and held it in 15 quarters.
  • Israel Englander's Galmed Pharmaceuticals position peaked at $4.48M in Q3 2018.
  • 10 funds tracked by Wall St. Rank held Galmed Pharmaceuticals as of Q4 2023.

Based on Millennium Management's 13F filing for Q4 2023, filed 14 Feb 2024.